Status:
COMPLETED
Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation
Lead Sponsor:
Valduce Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The optimal strategy to restore sinus rhythm in patients with atrial fibrillation (AF) of less than 48 hours' duration is still controversial. The investigators performed a controlled single-center tr...
Eligibility Criteria
Inclusion
- atrial fibrillation of less than 48 hours' duration.
Exclusion
- AF of more than 48 hours'
- hemodynamic instability
- acute onset atrial fibrillation due to acute coronary syndrome
- electrolyte disturbances
- sepsis
- fever
- hypothermia
- untreated hyperthyroidism
- use of antiarrhythmic drugs
- high embolic risk
- unclear duration of symptoms
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2008
Estimated Enrollment :
247 Patients enrolled
Trial Details
Trial ID
NCT00933634
Start Date
January 1 2006
End Date
November 1 2008
Last Update
July 7 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emergency Unit - Valduce Hospital
Como, Italy, 22100